| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 92.397 | 90.969 | 103.106 | 95.559 | 110.820 | 148.563 | 152.399 | 201.681 | 223.705 | 230.126 |
| Total Income - EUR | 92.398 | 90.969 | 103.107 | 95.561 | 110.822 | 148.565 | 152.432 | 201.683 | 223.707 | 230.165 |
| Total Expenses - EUR | 85.647 | 86.691 | 93.648 | 85.038 | 98.103 | 131.122 | 132.355 | 173.461 | 196.883 | 209.288 |
| Gross Profit/Loss - EUR | 6.750 | 4.278 | 9.459 | 10.523 | 12.720 | 17.443 | 20.077 | 28.222 | 26.823 | 20.877 |
| Net Profit/Loss - EUR | 5.564 | 3.368 | 8.100 | 9.567 | 11.611 | 16.334 | 18.552 | 26.193 | 24.647 | 15.129 |
| Employees | 3 | 4 | 4 | 3 | 3 | 3 | 2 | 3 | 2 | 2 |
Check the financial reports for the company - Farmacia Cordis S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.162 | 8.079 | 7.942 | 7.797 | 5.528 | 4.339 | 10.931 | 8.407 | 6.267 | 4.130 |
| Current Assets | 68.880 | 62.466 | 58.480 | 38.547 | 39.154 | 55.650 | 77.963 | 84.093 | 92.138 | 82.364 |
| Inventories | 9.089 | 9.122 | 8.839 | 8.322 | 16.543 | 14.507 | 25.281 | 26.975 | 28.635 | 19.714 |
| Receivables | 18.574 | 11.339 | 20.989 | 22.799 | 21.108 | 37.260 | 34.711 | 55.767 | 57.834 | 47.991 |
| Cash | 41.217 | 42.006 | 28.652 | 7.426 | 1.503 | 3.882 | 17.971 | 1.351 | 5.670 | 14.660 |
| Shareholders Funds | 40.429 | 43.385 | 30.611 | 17.268 | 11.662 | 17.438 | 26.486 | 26.242 | 24.695 | 15.178 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 36.613 | 27.160 | 35.811 | 29.076 | 33.020 | 42.550 | 62.408 | 66.509 | 74.222 | 71.619 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Cordis S.r.l.